← Back to Search

Procedure

Nasogastric Tubes for Bronchiolitis

N/A
Recruiting
Led By David Spiro, MD, MPH
Research Sponsored by Arkansas Children's Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of bronchiolitis by the attending physician
Ages 0 months to 23 months
Must not have
History of congenital heart disease
History of tracheostomy or current tracheostomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if placing a tube in the nose can help reduce breathing difficulty in babies with bronchiolitis who need oxygen therapy.

Who is the study for?
This trial is for babies and toddlers up to 23 months old with bronchiolitis who are receiving oxygen through a high-flow nasal cannula. It's not suitable for those with tracheostomy, short gut syndrome, congenital heart disease, G-tube dependence, cranio-facial anomalies or bacterial pneumonia.
What is being tested?
The study is testing if using nasogastric tubes to remove stomach contents can help ease breathing difficulties in young patients with bronchiolitis on high-flow oxygen therapy.
What are the potential side effects?
Potential side effects of nasogastric tube placement may include discomfort in the nose or throat, gagging during the procedure, risk of tube misplacement into the lungs which could cause injury or infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My doctor diagnosed me with bronchiolitis.
Select...
I am under 2 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was born with a heart condition.
Select...
I have had or currently have a tracheostomy.
Select...
I have been diagnosed with bacterial pneumonia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Respiratory status

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nasogastric tube placementExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Arkansas Children's Hospital Research InstituteLead Sponsor
138 Previous Clinical Trials
5,025,556 Total Patients Enrolled
David Spiro, MD, MPHPrincipal InvestigatorAR Children's Hospital

Media Library

Nasogastric tube placement (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04480970 — N/A
Respiratory Syncytial Virus Bronchiolitis Research Study Groups: Nasogastric tube placement
Respiratory Syncytial Virus Bronchiolitis Clinical Trial 2023: Nasogastric tube placement Highlights & Side Effects. Trial Name: NCT04480970 — N/A
Nasogastric tube placement (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04480970 — N/A
~11 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top